TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9740347

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training at 30% of maximum inspiratory mouth pressure for 30 min daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham training at 15% of maximum inspiratory mouth pressure
Number of subjects: 18
Study: 8092115

Group type: EXPERIMENTAL
Intervention: Continuous infusion of metoclopramide (regimen A)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Intermittent short infusion of metoclopramide (regimen B)
Number of subjects: 54
Study: 2968223

Group type: EXPERIMENTAL
Intervention: Thymoxamine eye drops (0.5%)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tropicamide (0.5%)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Tropicamide (1.0%)
Number of subjects: 12
Study: 6214996

Group type: EXPERIMENTAL
Intervention: Moxalactam (500 mg every 12 h)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Cefazolin (1 g every 12 h)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 89

Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 89
Study: 30218227

Group type: EXPERIMENTAL
Intervention: FGG + LLLT (test group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: FGG + placebo LLLT (control group)
Number of subjects: 30
Study: 27139726

Group type: EXPERIMENTAL
Intervention: Norepinephrine 5 µg ml-1
Number of subjects: 104

Group type: COMPARATOR
Intervention: Phenylephrine 100 µg ml-1
Number of subjects: 104
Study: 25954317

Group type: EXPERIMENTAL
Intervention: Ginger and artichoke supplementation
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 24622121

Group type: EXPERIMENTAL
Intervention: AAV1/SERCA2a gene therapy
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 22935527

Group type: COMPARATOR
Intervention: Statin therapy in non-CKD (n=4,747)
Number of subjects: 14706

Group type: COMPARATOR
Intervention: Statin therapy in mild CKD (n=2,135)
Number of subjects: 14706

Group type: COMPARATOR
Intervention: Statin therapy in severe CKD (n=229)
Number of subjects: 14706

Group type: COMPARATOR
Intervention: Statin therapy in HD (n=117)
Number of subjects: 14706
Study: 19663622

Group type: EXPERIMENTAL
Intervention: Efficacy (positive) messages (n = 68)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Risk (negative) messages (n = 67)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Delayed treatment control group (n = 68)
Number of subjects: 203
Study: 17464561

Group type: EXPERIMENTAL
Intervention: Esomeprazole, 20 mg bid with amoxicillin, 1000 mg bid, and clarithromycin, 500 mg bid for 1 week, followed by placebo for 3 weeks
Number of subjects: 374

Group type: COMPARATOR
Intervention: Omeprazole, 20 mg bid with amoxicillin, 1000 mg bid, and clarithromycin, 500 mg bid for 1 week, followed by omeprazole, 20 mg od for 3 weeks
Number of subjects: 374
Study: 15247714

Group type: COMPARATOR
Intervention: Control (no anesthesia)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: PNB (periprostatic nerve block)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: PNB plus rectal lidocaine gel
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 300
Study: 12566834

Group type: EXPERIMENTAL
Intervention: Intracystic chemotherapy with bleomycin (group A)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Intracystic chemo‐radiotherapy with bleomycin and (32)P (group B)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Intracystic radiotherapy with (32)P and 0.9% saline (group C)
Number of subjects: 19
Study: 9849419

Group type: EXPERIMENTAL
Intervention: Dacarbazine (DTIC) and Vindesine (V) with Cisplatin (P)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Dacarbazine (DTIC) and Vindesine (V) without Cisplatin (P)
Number of subjects: 326
Study: 7974580

Group type: EXPERIMENTAL
Intervention: Carotid angioplasty with transcranial Doppler monitoring
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Post-procedure monitoring
Number of subjects: 10
Study: 2605620

Group type: EXPERIMENTAL
Intervention: CAPS Phenytoin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Epanutin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CAPS Phenytoin and Epanutin
Number of subjects: 10
Study: 183462

Group type: EXPERIMENTAL
Intervention: Clofibrate
Number of subjects: 28
Study: 30488513

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting surgery plus medical therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 0
Study: 28387949

Group type: EXPERIMENTAL
Intervention: Mindfulness
Number of subjects: 57

Group type: COMPARATOR
Intervention: Attention-control
Number of subjects: 57

Group type: COMPARATOR
Intervention: Resting exposure
Number of subjects: 57
Study: 25931316

Group type: EXPERIMENTAL
Intervention: Pidotimod 400 mg per os twice daily for the last 10 days of each month from October 2013 to April 2014
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 23819489

Group type: EXPERIMENTAL
Intervention: Degradable magnesium-based MgYREZr screws
Number of subjects: 26

Group type: COMPARATOR
Intervention: Titanium screws
Number of subjects: 26
Study: 21857015

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES 130/0.4)
Number of subjects: 115

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 115
Study: 19564809

Group type: EXPERIMENTAL
Intervention: Topical and intraurethral lidocaine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Topical lubricant control
Number of subjects: 45
Study: 17584569

Group type: EXPERIMENTAL
Intervention: abciximab
Number of subjects: 2022

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2022
Study: 15015186

Group type: EXPERIMENTAL
Intervention: EVAR
Number of subjects: 900

Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: EVAR with best medical treatment
Number of subjects: 900

Group type: COMPARATOR
Intervention: Best medical treatment alone
Number of subjects: 900
Study: 11163386

Group type: EXPERIMENTAL
Intervention: Single-unit all-porcelain crowns (SUAPC) preparation with acid etching
Number of subjects: 40
Study: 9547840

Group type: EXPERIMENTAL
Intervention: Oxylator EM100
Number of subjects: 72

Group type: COMPARATOR
Intervention: Bag ventilation
Number of subjects: 72
Study: 7828353

Group type: EXPERIMENTAL
Intervention: Growth hormone therapy (0.2 IU/kg/week for 6 months)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Growth hormone therapy (12 months)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: In vitro glucocorticoid sensitivity during GH therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo arm during open phase of GH therapy
Number of subjects: 19
Study: 3277478

Group type: EXPERIMENTAL
Intervention: Morphine 0.25 mg (group I, n = 11)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Morphine 0.1 mg (group II, n = 10)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Saline (group III, placebo group, n = 12)
Number of subjects: 33
Study: 31314920

Group type: COMPARATOR
Intervention: Intralesional bleomycin (GA)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Electroporation and intralesional bleomycin (GB)
Number of subjects: 44
Study: 27558785

Group type: EXPERIMENTAL
Intervention: Brief Impact of Vision Impairment (IVI) questionnaire
Number of subjects: 416
Study: 24913915

Group type: EXPERIMENTAL
Intervention: Biodex System 3 Pro
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cybex Humac Norm Model 770
Number of subjects: 25
Study: 23168172

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (VAS) at birth
Number of subjects: 471
Study: 21646051

Group type: EXPERIMENTAL
Intervention: Memantine treatment
Number of subjects: 47
Study: 18374542

Group type: EXPERIMENTAL
Intervention: Cognitive Adaptation Training (CAT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Generic Environmental Supports (GES)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 120
Study: 17391577

Group type: EXPERIMENTAL
Intervention: Standardized communication system (SCS) providing detailed reports on ED visits.
Number of subjects: 2022

Group type: COMPARATOR
Intervention: Mailed copies of ED notes (control group).
Number of subjects: 2022
Study: 12571662

Group type: EXPERIMENTAL
Intervention: Psyllium-enriched pasta (1.7 g psyllium)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pasta with 30 g sunflower oil and 3 g sodium propionate
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control pasta (without psyllium, fat, or sodium propionate)
Number of subjects: 10
Study: 10696843

Group type: EXPERIMENTAL
Intervention: Endosonography
Number of subjects: 0
Study: 9172026

Group type: EXPERIMENTAL
Intervention: General anesthesia plus lumbar epidural anesthesia (Group CEGA)
Number of subjects: 37

Group type: COMPARATOR
Intervention: General anesthesia (Group GA)
Number of subjects: 37
Study: 8227791

Group type: EXPERIMENTAL
Intervention: 40-ms impulse/high impedance electrode
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 40-ms impulse/low impedance electrode
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 20-ms impulse/high impedance electrode
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 20-ms impulse/low impedance electrode
Number of subjects: 32
Study: 3543072

Group type: EXPERIMENTAL
Intervention: 5% fluorouracil under occlusion, mean application of 2 to 3 days per week
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 5% fluorouracil under occlusion
Number of subjects: 13
Study: 30662380

Group type: EXPERIMENTAL
Intervention: Play-Informed, Caregiver-Implemented, Home-Based Intervention (PICIHBI)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional one-on-one occupational therapy interventions
Number of subjects: 24
Study: 27133814

Group type: EXPERIMENTAL
Intervention: SC plus true acupuncture
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: SC plus non-penetrating acupuncture
Number of subjects: 125

Group type: COMPARATOR
Intervention: SC
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: SC, SC plus true acupuncture, SC plus non-penetrating acupuncture
Number of subjects: 125
Study: 25511324

Group type: EXPERIMENTAL
Intervention: Alternative biomass stove with a chimney
Number of subjects: 0

Group type: COMPARATOR
Intervention: Liquid propane gas stove
Number of subjects: 0
Study: 22398158

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention to improve self-management of anxiety (n = 50)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Routine clinical care (n = 44)
Number of subjects: 94
Study: 20122815

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition supplemented with glutamine 0.18 g kg(‐1) d(‐1) for 20 d
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard parenteral nutrition
Number of subjects: 36
Study: 17768157

Group type: EXPERIMENTAL
Intervention: Ibuprofen (10 mg/kg)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Indometacin (0.2 mg/kg)
Number of subjects: 119
Study: 16429187

Group type: EXPERIMENTAL
Intervention: Glass ionomer cement (Fuji I)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Resin cement (Variolink II)
Number of subjects: 32
Study: 12701260

Group type: EXPERIMENTAL
Intervention: Subarachnoid anesthesia with 5 mg of bupivacaine and 15 micrograms of fentanyl (Group F)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Subarachnoid anesthesia with 7.5 mg bupivacaine (Group B)
Number of subjects: 60
Study: 10586384

Group type: EXPERIMENTAL
Intervention: 6-week program designed to improve coping
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 1-hr coping 'refresher' sessions at 5, 11, and 17 months
Number of subjects: 118

Group type: COMPARATOR
Intervention: No refresher sessions following the 6-week course
Number of subjects: 118
Study: 8914088

Group type: EXPERIMENTAL
Intervention: Sublingual apomorphine (10 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sublingual apomorphine with Vitamin C (250 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Subcutaneous apomorphine
Number of subjects: 13
Study: 1860146

Group type: EXPERIMENTAL
Intervention: Ivermectin 100 micrograms/kg given at 2-week intervals for 6 doses
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 28
Study: 6614959

Group type: EXPERIMENTAL
Intervention: Intra-arterial reserpine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 24
Study: 29365157

Group type: EXPERIMENTAL
Intervention: Passive inference of smoking status from user generated content (UGC)
Number of subjects: 826
Study: 30413518

Group type: EXPERIMENTAL
Intervention: Plagiarism policies in journals
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Text matching software
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Extent of plagiarism measured by Turnitin
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Plagiarism severity
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Plagiarism occurrence by section
Number of subjects: 495
Study: 26450146

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (H) 10 mg p.o. + placebo i.v.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fludrocortisone (FC) 0.1 mg p.o. + placebo i.v.
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fludrocortisone (FC) 0.1 mg p.o. and Hydrocortisone (H) 10 mg p.o. + placebo i.v.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo p.o. + placebo i.v.
Number of subjects: 10
Study: 24200231

Group type: EXPERIMENTAL
Intervention: 3% diquafosol ophthalmic solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 20
Study: 22360384

Group type: EXPERIMENTAL
Intervention: Interpersonal therapy (IPT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Supportive therapy (ST)
Number of subjects: 53
Study: 20093075

Group type: EXPERIMENTAL
Intervention: Auditory BCI using a three-stimulus paradigm with varying target stimuli (loudness, pitch, direction)
Number of subjects: 20
Study: 18271229

Group type: EXPERIMENTAL
Intervention: Blood-letting puncture at 12 Jing-well points of the hand combined with fuming and washing with herbal lotion
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral administration of diuretic
Number of subjects: 80
Study: 15613431

Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 12480038

Group type: EXPERIMENTAL
Intervention: Propafenone SR 325 mg twice daily
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: Propafenone SR 425 mg twice daily
Number of subjects: 594

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 594
Study: 10074017

Group type: EXPERIMENTAL
Intervention: Programme to coordinate preventive care led by specialist liaison nurses
Number of subjects: 597

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 597
Study: 7585844

Group type: EXPERIMENTAL
Intervention: Risperidone (9.4 mg/d for 1 year)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Risperidone (2 years treatment)
Number of subjects: 32
Study: 2262587

Group type: EXPERIMENTAL
Intervention: Chlorhexidine acetate (CHX) gum, 5 mg per piece, chewed 2 pieces 2 times daily for 10 min
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Chlorhexidine acetate (CHX) gum, 4 mg per piece, chewed 2 pieces 2 times daily for 6 days
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Chlorhexidine acetate (CHX) gum, 3 mg per piece, chewed 2 pieces 2 times daily for 6 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Hibitane Dental (HD) rinse
Number of subjects: 14

Group type: COMPARATOR
Intervention: Gum base without CHX or sweetening agent
Number of subjects: 14
Study: 477315

Group type: EXPERIMENTAL
Intervention: Ovral
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Norinyl
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Both brands
Number of subjects: 1200
Study: 31858394

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (1.5 mg/kg) 5 min before induction, followed by infusion (2 mg/kg/h) until the end of surgery
Number of subjects: 58

Group type: COMPARATOR
Intervention: 0.9% saline solution (placebo) and infusion of 0.9% saline solution during surgery
Number of subjects: 58
Study: 30996008

Group type: EXPERIMENTAL
Intervention: Hypofractionated stereotactic radiotherapy (HFSRT) concurrent with temozolomide (TMZ) at a dosage of 75 mg/m2 per day for at least 20 days
Number of subjects: 54
Study: 29072375

Group type: EXPERIMENTAL
Intervention: Microneedling with 70% glycolic acid peel (group 2)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Microneedling alone (group 1)
Number of subjects: 60
Study: 25988992

Group type: EXPERIMENTAL
Intervention: Maternal skin-to-skin contact (M-SSC)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Paternal skin-to-skin contact (P-SSC)
Number of subjects: 28
Study: 23884497

Group type: EXPERIMENTAL
Intervention: LiquiBand® Flow Control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High Viscosity Dermabond™
Number of subjects: 0
Study: 21658782

Group type: EXPERIMENTAL
Intervention: 60 mg of d,l-fenfluramine (FEN)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 19171319

Group type: EXPERIMENTAL
Intervention: Follicular phase, quit >= 5 days
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Luteal phase, quit >= 5 days
Number of subjects: 152

Group type: COMPARATOR
Intervention: Follicular phase, quit < 24 h
Number of subjects: 152

Group type: COMPARATOR
Intervention: Luteal phase, quit < 24 h
Number of subjects: 152
Study: 16954358

Group type: EXPERIMENTAL
Intervention: Fast-food meal estimation (study 1)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Fast-food meal estimation (study 2)
Number of subjects: 145
Study: 14974636

Group type: COMPARATOR
Intervention: Conventional phototherapy (CPT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Fibre-optic phototherapy (FPT)
Number of subjects: 23
Study: 11818170

Group type: EXPERIMENTAL
Intervention: High emotion events
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low emotion events
Number of subjects: 0
Study: 9651889

Group type: EXPERIMENTAL
Intervention: Golden-Ankle prosthetic foot
Number of subjects: 5

Group type: COMPARATOR
Intervention: SACH prosthetic foot
Number of subjects: 5

Group type: COMPARATOR
Intervention: Seattle prosthetic foot
Number of subjects: 5
Study: 7661637

Group type: EXPERIMENTAL
Intervention: Urethropexy (Kelly, Raz, Marshall‐Marchetti‐Krantz, Burch or simplified Ramirez technique)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Urethropexy
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Simplified Ramirez technique
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Kelly technique
Number of subjects: 70
Study: 2526239

Group type: EXPERIMENTAL
Intervention: Cyclo provera (Depo‐medroxy Progesterone Acetate 25 mg and Estradiol Cypionate 5 mg)
Number of subjects: 206

Group type: COMPARATOR
Intervention: HRP-102 (Norethisterone enanthate 50 mg and Estradiol Valerate 5 mg)
Number of subjects: 206
Study: 153730

Group type: EXPERIMENTAL
Intervention: Zinc sulfate
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 52
Study: 27469458

Group type: EXPERIMENTAL
Intervention: Doctor Office Collaborative Care (DOCC)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 321
Study: 25824428

Group type: EXPERIMENTAL
Intervention: Non-motorized curved treadmill (NMCT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard motorized treadmill (SMT)
Number of subjects: 10
Study: 23607542

Group type: EXPERIMENTAL
Intervention: Oral vestibular cleansing capability assessment (measuring rice remaining in the oral vestibule)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Masticatory efficiency assessment (measuring glucose eluted from gummy jelly)
Number of subjects: 30
Study: 20974068

Group type: EXPERIMENTAL
Intervention: Systematic theory-based problem-solving approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 19153091

Group type: EXPERIMENTAL
Intervention: 100 mg aspirin daily starting on the first day of gonadotrophin stimulation
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: 100 mg aspirin daily
Number of subjects: 122
Study: 17924016

Group type: EXPERIMENTAL
Intervention: General anesthesia with autonomous respiration (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: General anesthesia with control respiration (Group C)
Number of subjects: 40
Study: 15756164

Group type: EXPERIMENTAL
Intervention: 3‐HR hold-relax PNF stretch
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 6‐HR hold-relax PNF stretch
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10‐HR hold-relax PNF stretch
Number of subjects: 60
Study: 11518851

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nebivolol and Atenolol
Number of subjects: 25
Study: 9778268

Group type: EXPERIMENTAL
Intervention: Low-dose oral steroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon beta-1b (IFNbeta-1b) therapy
Number of subjects: 0
Study: 29490097

Group type: EXPERIMENTAL
Intervention: High-fat breakfast (FB; 35% carbohydrate, 20% protein, 45% fat; n = 13)
Number of subjects: 29

Group type: COMPARATOR
Intervention: High-carbohydrate breakfast (CB; 60% carbohydrate, 20% protein, 20% fat; n = 16)
Number of subjects: 29
Study: 28857982

Group type: EXPERIMENTAL
Intervention: Horizontal mattress suturing technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Simple interrupted suturing technique
Number of subjects: 30
Study: 26228433

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with gemcitabine and cisplatin for 24 weeks
Number of subjects: 425

Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 425
Study: 23755969

Group type: EXPERIMENTAL
Intervention: Triple therapy (methotrexate, sulfasalazine, and hydroxychloroquine)
Number of subjects: 353

Group type: EXPERIMENTAL
Intervention: Etanercept plus methotrexate
Number of subjects: 353

Group type: COMPARATOR
Intervention: Both groups (after switching therapies)
Number of subjects: 353
Study: 19574405

Group type: EXPERIMENTAL
Intervention: computer‐tailored e‐mail
Number of subjects: 458

Group type: COMPARATOR
Intervention: generic, non‐tailored e‐mail
Number of subjects: 458
Study: 16828780

Group type: EXPERIMENTAL
Intervention: cerivastatin
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: nifedipine
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: cerivastatin+nifedipine
Number of subjects: 289

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 289